Table 3.
Frequencies of patients who screened positive for lyso-Gb3 and class 1 GLA mutations, grouped according to the specialty of the referring clinic
| Males | Cardiology | Nephrology | Neurology | Pediatrics | Total |
|---|---|---|---|---|---|
| Lyso-Gb3-positive patients (%) | 3/511 (0.6) | 3/508 (0.6) | 0/286 (0) | 2/19 (10.5) | 8/1,324 (0.6) |
| GLA mutation (%) | 3/511 (0.6) | 2/508 (0.4) | 0/286 (0) | 2/19 (10.5) | 7/1,324 (0.5) |
| Classic type | 0 | 0 | 0 | 2 | 2 |
| Late-onset type | 3 | 2 | 0 | 0 | 5 |
| Females | Cardiology | Nephrology | Neurology | Pediatrics | Total |
| Lyso-Gb3-positive patients (%) | 8/224 (3.6) | 5/550 (0.9) | 1/226 (0.4) | 0/35 (0) | 14/1,035 (1.4) |
| GLA mutation (%) | 3/224 (1.3) | 2/550 (0.4) | 1/226 (0.4) | 0/35 (0) | 6/1,035 (0.6) |
| Classic type | 3 | 1 | 1 | 0 | 5 |
| Late-onset type | 0 | 1 | 0 | 0 | 1 |